(Q45391150)

English

Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis

scientific article published on 9 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

Bacillus anthracis

1 reference

based on heuristic

inferred from title

author name string

Ying Yin

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jun Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Dayong Dong

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Shuling Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Qiang Guo

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Xiaohong Song

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Guanlin Li

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ling Fu

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Junjie Xu

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Wei Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

9 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

5814-5821

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Anthrax toxin: receptor binding, internalization, pore formation, and translocation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Anthrax vaccines: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Anthrax: the disease in relation to vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Anthrax vaccine: short-term safety experience in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Monitoring anthrax vaccine safety in US military service members on active duty: surveillance of 1998 hospitalizations in temporal association with anthrax immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Rabies virus glycoprotein as a carrier for anthrax protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Molecular basis for improved anthrax vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Crystal structure of the anthrax toxin protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Hepatitis B virus core particles as epitope carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Search for correlates of protective immunity conferred by anthrax vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

HBV core particles as a carrier for B cell/T cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Immunological properties of hepatitis B core antigen fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Hepatitis B core particles as a universal display model: a structure-function basis for development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.08.031

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45391150&oldid=2076353015"